Related Experiment Videos
Indoprofen in juvenile chronic arthritis
Insights
Indoprofen effectively treated juvenile chronic arthritis in children, outperforming aloxiprin in reducing swelling and pain. This non-steroidal anti-inflammatory drug demonstrated good tolerability for pediatric patients.
Area of Science:
- Pediatric Rheumatology
- Pharmacology
- Clinical Trials
Background:
- Juvenile chronic arthritis (JCA) is a debilitating condition in children.
- Current treatments for JCA have limitations in efficacy and tolerability.
- Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for symptom management.
Purpose of the Study:
- To compare the efficacy and safety of indoprofen versus aloxiprin in children with JCA.
- To evaluate the impact of indoprofen on key JCA symptoms like swelling, pain, and joint function.
Main Methods:
- A comparative study involving children diagnosed with juvenile chronic arthritis.
- Patients received either indoprofen (10-12 mg/kg) or aloxiprin (80 mg/kg).
- Outcomes assessed included soft tissue swelling, joint limitation, pain, morning stiffness, and grip strength.
Main Results:
- Indoprofen showed significant superiority over aloxiprin in reducing soft tissue swelling and joint limitation.
- Indoprofen was effective in alleviating pain and morning slowness.
- Improvements in grip strength were observed with indoprofen treatment.
- The drug was well-tolerated by the pediatric participants.
Conclusions:
- Indoprofen is a safe and effective treatment option for children with juvenile chronic arthritis.
- Indoprofen offers significant benefits over aloxiprin for managing JCA symptoms.
- Further research may explore long-term efficacy and safety profiles.
Abstract:
Indoprofen at 10-12 mg/kg body weight was compared with aloxiprin at 80 mg/kg body weight in children suffering from juvenile chronic arthritis. Indoprofen was significantly superior to aloxiprin in reducing soft tissue swelling and joint limitation and was effective in relieving pain and morning slowness and improving grip strength. The drug was well tolerated and is a satisfactory agent for the treatment of chronic arthritis in children.